In this episode, you will discover: 

• Why price transparency is important
• How to understand the impact between a $0 option and a $250 option in the moment of decision
• How data transparency impacts patient access and health equity 

Key Takeaways: 

• Moving to a more consumer-directed and consumer-focused model means focusing on creating more transparency on the area of pricing. By bringing this information upstream, we will be able to build trust between the patient and the provider. 
• The difference between a $250 drug and a $0 drug can be meaningful to a lot of people. Providing this option isn’t impossible, it’s only a matter of getting the right answer to the right decision-maker when those things are happening. 
• Consumer-driven healthcare is the most important health equity issue to solve. Half of America can’t incur $1,000 of unexpected expenses without financial ruin. Providing information to the right people can go a long way in contributing to the solution. 

“Things that we can automate, we should automate.” - Kyle Kiser

Resources: 

Website:  https://arrivehealth.com/ 

LinkedIn: https://www.linkedin.com/in/kyle-kiser-68ba218/ 

Learn more from Carrie and Rebecca: 

Healthcare Insights (a monthly deep dive into specific topics for innovators): https://nixongwiltlaw.com/healthcare-insights

Telehealth/Virtual Care Mgmt Update (a biweekly LinkedIn newsletter tracking legal and policy changes across the nation): https://www.linkedin.com/newsletters/telehealth-virtual-care-update-6901900767960068096/ 

Website: https://nixongwiltlaw.com/ 

Carrie on LinkedIn: https://www.linkedin.com/in/carrienixon/ 

Rebecca on LinkedIn: https://www.linkedin.com/in/rebeccagwilt/

NGL on LinkedIn: https://www.linkedin.com/company/nixon-gwilt-law/